Crown Castle (CCI), and Corning (GLW) could potentially benefit from AT&T's (T) $250B spending plan, as per an SA analyst.

Shares of uniQure N.V. QURE plunged 31.8% in a week, primarily after the company announced a disappointing regulatory update ...

10 min read | The FDA wants more data before approving AMT-130 for Huntington’s disease in the U.S. On March 2026, uniQure ...

Qure stock plunged 45% after FDA rejected AMT-130 approval pathway, requiring new randomized trial for Huntington's disease ...

分析师将密切关注uniQure与FDA安排的A类会议的任何最新进展,该会议旨在讨论AMT-130的生物制品许可申请数据包。A类会议是为陷入停滞的项目保留的紧急高优先级讨论,通常在30天内举行,官方会议纪要通常会在不久后发布。

Dispersive Holdings completed a successful pilot with an American Tower Edge Data Center, focused on AI and high-performance edge workloads. The pilot delivered improvements in throughput, security, ...

汽车+航空航天+机器人业务布局多元，2025年前三季度业绩稳健增长： ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

In a strikingly blunt briefing, a senior FDA official accused uniQure of pushing “distorted” data to mask a “failed” therapy ...

Dispersive’s trials saw its Trusted Cloud Edge (TCE) multipath transport fabric paired with Vertical Data’s high-density GPU ...

马萨诸塞州列克星敦和阿姆斯特丹 - uniQure N.V. (NASDAQ:QURE) 周一宣布,美国食品药品监督管理局表示无法同意其AMT-130的I/II期研究数据与外部对照组的比较足以支持这款在研亨廷顿病基因疗法的上市申请。该消息公布后,该股在过去一周暴跌36%,目前交易价格为$15.63,而其52周高点为$71.50。

If you are wondering whether American Tower is priced fairly or offering value right now, you are not alone. This article is designed to help you unpack that question using clear numbers. The stock ...